Bioptik Technology Capital Reinvestment Ratio
Bioptik Technology capital reinvestment ratio. Bioptik Technology (4161) has a Capital Reinvestment Ratio of 0.09x as of December 2025, meaning it reinvests 0% of its operating cash flow (NT$53.21 Million) in capital expenditures (NT$4.94 Million). Check how aggressively does Bioptik Technology reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Bioptik Technology (2017–2025)
Capital reinvestment ratio of Bioptik Technology from 2017 to 2025. This chart tracks Bioptik Technology's Capital Reinvestment Ratio across 8 annual periods. Also explore 4161 net assets growth trend to track the company's year-over-year net asset growth rate.
Bioptik Technology Capital Reinvestment Ratio by Year (2017–2025)
Bioptik Technology capital reinvestment ratio by year from 2017 to 2025. For the full cash flow conversion analysis, see Bioptik Technology operating cash flow efficiency.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.38x | NT$59.99 Million | NT$22.80 Million | ▲ +289.4% |
| 2024 | 0.10x | NT$158.82 Million | NT$15.51 Million | ▼ -35.2% |
| 2023 | 0.15x | NT$205.95 Million | NT$31.04 Million | ▼ -51.4% |
| 2022 | 0.31x | NT$55.06 Million | NT$17.08 Million | ▼ -84.5% |
| 2020 | 2.01x | NT$6.57 Million | NT$13.18 Million | ▲ +200.0% |
| 2019 | 0.67x | NT$41.03 Million | NT$27.42 Million | ▼ -45.1% |
| 2018 | 1.22x | NT$41.83 Million | NT$50.96 Million | ▼ -78.6% |
| 2017 | 5.69x | NT$11.02 Million | NT$62.72 Million | — |